Literature DB >> 24443149

Reply: To PMID 23996730.

Ling Yang1, Ekihiro Seki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24443149      PMCID： PMC4328032          DOI： 10.1002/hep.27019

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  10 in total

1.  Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.

Authors:  Kouichi Miura; Yuzo Kodama; Sayaka Inokuchi; Bernd Schnabl; Tomonori Aoyama; Hirohide Ohnishi; Jerrold M Olefsky; David A Brenner; Ekihiro Seki
Journal:  Gastroenterology       Date:  2010-03-27       Impact factor: 22.682

2.  Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice.

Authors:  Ling Yang; Yoon Seok Roh; Jingyi Song; Bi Zhang; Cheng Liu; Rohit Loomba; Ekihiro Seki
Journal:  Hepatology       Date:  2013-12-18       Impact factor: 17.425

Review 3.  Avenues of communication between the brain and tissues/organs involved in energy homeostasis.

Authors:  Tetsuya Yamada; Hideki Katagiri
Journal:  Endocr J       Date:  2007-05-18       Impact factor: 2.349

4.  Inducible liver-specific knockdown of protein tyrosine phosphatase 1B improves glucose and lipid homeostasis in adult mice.

Authors:  C Owen; E K Lees; L Grant; D J Zimmer; N Mody; K K Bence; M Delibegović
Journal:  Diabetologia       Date:  2013-07-06       Impact factor: 10.122

5.  Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction.

Authors:  M D Michael; R N Kulkarni; C Postic; S F Previs; G I Shulman; M A Magnuson; C R Kahn
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

6.  Liver-specific p70 S6 kinase depletion protects against hepatic steatosis and systemic insulin resistance.

Authors:  Eun Ju Bae; Jianfeng Xu; Da Young Oh; Gautam Bandyopadhyay; William S Lagakos; Malik Keshwani; Jerrold M Olefsky
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

7.  Kupffer cell activation is a causal factor for hepatic insulin resistance.

Authors:  Nicolas Lanthier; Olivier Molendi-Coste; Yves Horsmans; Nico van Rooijen; Patrice D Cani; Isabelle A Leclercq
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-10-29       Impact factor: 4.052

8.  Hepatic NF-kappa B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis.

Authors:  F Thomas Wunderlich; Tom Luedde; Stephan Singer; Marc Schmidt-Supprian; Julia Baumgartl; Peter Schirmacher; Manolis Pasparakis; Jens C Brüning
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-23       Impact factor: 11.205

9.  Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.

Authors:  Mara Monetti; Malin C Levin; Matthew J Watt; Mini P Sajan; Stephen Marmor; Brian K Hubbard; Robert D Stevens; James R Bain; Christopher B Newgard; Robert V Farese; Andrea L Hevener; Robert V Farese
Journal:  Cell Metab       Date:  2007-07       Impact factor: 27.287

10.  Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis.

Authors:  Sudha B Biddinger; Antonio Hernandez-Ono; Christian Rask-Madsen; Joel T Haas; José O Alemán; Ryo Suzuki; Erez F Scapa; Chhavi Agarwal; Martin C Carey; Gregory Stephanopoulos; David E Cohen; George L King; Henry N Ginsberg; C Ronald Kahn
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.